Notably, copy numbers (CNs) for cyclin-dependent kinase inhibitor (CDKN) 2A (CDKN2A) and CDKN2B in the sarcoma tissue were 0.6 and 0.5, respectively (Table 1). This evidence concerns the gene CDKN2A and sarcoma.